share_log

HC Wainwright & Co. Maintains Buy on Ikena Oncology, Lowers Price Target to $11

Benzinga ·  Nov 9, 2023 17:53

HC Wainwright & Co. analyst Andres Maldonado maintains Ikena Oncology (NASDAQ:IKNA) with a Buy and lowers the price target from $18 to $11.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment